Potential integration of four weight loss applications, including the provision of medication, is being examined by the NHS in England as part of preliminary health guidelines.
Given that 30-70% of the population lacks access to weight management services within their regions, these apps aim to mitigate waiting times for treatment, seeking to address this gap.
Weight loss medications can be prescribed alongside recommended practices such as healthy dietary habits, physical activity, and psychological support.
Nevertheless, the much-anticipated drug Wegovy is yet to make its debut in the UK market. The manufacturer, Novo Nordisk, recently announced that it is limiting the number of doses allocated to various nations to ensure patients receive comprehensive all-encompassing care and support upon initiation of the drug.
The company also manufactures the weight loss drug Saxenda, also recognized as liraglutide, which is currently available.
Outlined in the preliminary recommendations by the National Institute for Health and Care Excellence (NICE), the NHS has the option to employ the four apps while accruing evidence regarding their cost-effectiveness over the forthcoming four years.
The efficacy of these applications will be evaluated based on parameters like alterations in individuals’ weight, program completion frequency, required appointments, and the expense associated with prescribed medications.
NICE’s calculations indicate that these apps could potentially cater to up to 48,000 individuals, consequently saving an estimated 145,000 hours of medical professionals’ time.
For some patients, access to the apps might entail provision of tablet computers and mobile internet connectivity, according to supplementary information provided by NICE.
Three additional apps necessitate further research before being considered for NHS integration, NICE has determined.
The technological solutions aim to provide support for individuals who cannot attend in-person sessions with weight management services, encompassing 10-30% of individuals, or those facing challenges in accessing local assistance or who find themselves on waiting lists.
